Cardiac stem cell therapy: progress from the bench to bedside

Lovell, Matthew J.; Mathur, Anthony
October 2010
Heart;Oct2010, Vol. 96 Issue 19, p1531
Academic Journal
In the rush to assess the role of stem cell therapy for cardiovascular disease the details of translation are easily overlooked. This review summarises the progress to date in translating the exciting preclinical results of cardiac repair into man and considers the questions that this area of research has stimulated about the challenges of moving from bench to bedside.


Related Articles

  • Perspective of the Stem Cell therapy in Cardiovascular Disease. Eschweiler, Tiffany; Yucui Zhu; Delatorre, Ludwika E.; Yan Yang; Hongbao Ma; Huaijie Zhu // Nature & Science;Feb2012, Vol. 10 Issue 2, p142 

    Stem cells are population of immature tissue precursor cells that is capable of self-renewal and provision of replacement cells for many tissues. The regenerative cardiovascular medicine to use stem cell therapy that is a novel approach is feasible, safe and potentially beneficial in patient...

  • Stem Cells in the Treatment of Cardiovascular Disease-An Overview. Hotkar, Amita; Balinsky, Warren // Stem Cell Reviews & Reports;Jun2012, Vol. 8 Issue 2, p494 

    CVD irreversibly damage the cardiomyocytes, the heart muscle cells. This loss triggers a cascade of detrimental events, including formation of scar tissue, an overload of blood flow and pressure capacity, the overstretching of viable cardiac cells, leading to heart failure and eventual death....

  • Embryonic Stem Cells help Patents, Not Patients. Debaets, Amy Michelle // Ethics & Medicine: An International Journal of Bioethics;Spring2006, Vol. 22 Issue 1, p64 

    Discusses the scientific and therapeutic differences between somatic and embryonic stem cells, based on an article by Jean Swanson in the January 3, 2006 issue of the "St. Paul Pioneer Press." Therapeutic use of nonembryonic stem cells; Financial rationale behind embryonic stem cell research.

  • Stem-cell-based therapy and lessons from the heart. Passier, Robert; van Laake, Linda W.; Mummery, Christine L. // Nature;5/15/2008, Vol. 453 Issue 7193, p322 

    The potential usefulness of human embryonic stem cells for therapy derives from their ability to form any cell in the body. This potential has been used to justify intensive research despite some ethical concerns. In parallel, scientists have searched for adult stem cells that can be used as an...

  • Intrapericardial Administration of Mesenchymal Stem Cells in a Large Animal Model: A Bio-Distribution Analysis. Blázquez, Rebeca; Sánchez-Margallo, Francisco Miguel; Crisóstomo, Verónica; Báez, Claudia; Maestre, Juan; García-Lindo, Mónica; Usón, Alejandra; Álvarez, Verónica; Casado, Javier G. // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    The appropriate administration route for cardiovascular cell therapy is essential to ensure the viability, proliferative potential, homing capacity and implantation of transferred cells. At the present, the intrapericardial administration of pharmacological agents is considered an efficient...

  • From the Editor's Perspective:New Directions and New Sources for Stem Cells [Hot Topic: Stem Cells (Guest Editor: Feng C. Zhou)]. Maiese, Kenneth // Current Neurovascular Research;Jul2004, Vol. 1 Issue 3, p193 

    From its initial conception, this special issue on stem cells was intended to showcase the potential therapeutic utilityof stem cells as well as to initiate scientific debate concerning the ability of stem cells to lead to viable tissueregeneration as well as functional plasticity in an organism...

  • Cell Therapy Still Progressing Despite Many Challenges. Moran, Nuala // BioWorld Today;7/16/2012, Vol. 23 Issue 136, p1 

    The article focuses on the challenges facing the biotechnology industry in attempts to get cell therapies to market. Tim Allsopp, head of external research in regenerative medicine at Pfizer Inc., says that such therapies are being tested in intractable diseases in untreatable patients. He adds...

  • Potential clinical applications using stem cells derived from human umbilical cord blood. Ghen, M. J.; Roshan, R.; Roshan, R. O.; Blyweiss, D. J.; Corso, N.; Khalili, B.; Zenga, W. T. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Oct2006, Vol. 13 Issue 4, p562 

    There is an abundance of clinical applications using human umbilical cord blood (HUCB) as a source for stem cell populations. Other than haematopoietic progenitors, there are mesenchymal, endothelial stem cells and neuronal precursors, in varying quantities, that are found in human umbilical...

  • The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy. Wang, Xianyun; Zhang, Jun; Zhang, Fan; Li, Jing; Li, Yaqi; Tan, Zirui; Hu, Jie; Qi, Yixin; Li, Quanhai; Yan, Baoyong // Stem Cells International;5/26/2015, Vol. 2015, p1 

    Ischemic cardiomyopathy (ICM) is becoming a leading cause of morbidity and mortality in the whole world. Stem cell-based therapy is emerging as a promising option for treatment of ICM. Several stem cell types including cardiac-derived stem cells (CSCs), bone marrow-derived stem cells,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics